Market Overview:
The global bilastine market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. Bilastine is a histamine H1 receptor antagonist used in the treatment of urticaria, allergic rhinitis, and allergic rhinoconjunctivitis. The increasing prevalence of allergies and asthma, rising awareness about the benefits of bilastine over other antihistamines, and growing demand for better-tolerated medications are some major factors driving the growth of this market. However, patent expiries for key bilastine products could hamper market growth in the coming years. The global bilastine market can be segmented on the basis of type into hospital-based and drug store-based segments. On the basis of application, it can be divided into urticaria, allergic rhinitis, and allergic rhinoconjunctivitis segments.
Product Definition:
Bilastine is a medication used to treat allergies. It is a histamine H1 receptor antagonist that works by blocking the effects of histamine in the body. This can help to relieve symptoms such as itching, sneezing, and congestion.
Hospital:
Hospital is a new entrant in the Bilastine market. It is used to treat severe heart failure and to improve survival rates after an acute coronary syndrome (ACS) has occurred. Hospital works by increasing the blood flow through the body so that more oxygen and nutrients can get to tissue cells, especially in cases of low blood sugar or if a person has been without food for long term.
Drug Store:
A drug store is a retail shop that sells medicines and pharmaceutical products. They are usually located in the central parts of a city or town, near hospitals and other health care facilities to serve the customers better.
The bilastine market is expected to grow at a significant rate during the forecast period owing to increasing prevalence of glaucoma across the globe coupled with rising awareness about this disease among people especially in developing countries like India, China, etc.
Application Insights:
Urticaria application segment led the global market in 2017. It is estimated to continue leading over the forecast period as well. Bilastine is used for treating urticaria, a common skin condition characterized by hives or welts on the body surface, which occur due to an allergic reaction. The drug has been approved by U.S FDA and Health Canada for this purpose only and hence would be expected to witness high demand from across regions especially during allergy season when people are prone to have reactions due to various allergens such as dust mites, animal dander etc., coming in contact with the skin surface.
The allergic rhinitis segment is anticipated to grow at a lucrative CAGR of XX% over the forecast period owingto increasing awareness about allergies among population globally coupled with rising number of patients reporting about their symptoms including nasal congestion.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing prevalence of urticaria and other allergic disorders, rising awareness about treatment options, availability of a wide range of prescription drugs, and presence of well-established healthcare facilities. Moreover, high adoption rate for technologically advanced medical products is also expected to drive demand for bilastine in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rapid economic development coupled with improving healthcare infrastructure and growing patient awareness regarding available treatment options. Furthermore, increasing number of product launches coupled with expansion strategies adopted by leading manufacturers are some factors responsible for driving demand in this region. For instance; Sun Pharmaceutical Industries Ltd.
Growth Factors:
- Increasing prevalence of allergic rhinitis and asthma
- Rising awareness about the benefits of bilastine over other antihistamines
- Growing demand for better-tolerated medications with fewer side effects
- Availability of bilastine in generic form
- Launch of new products by key players
Scope Of The Report
Report Attributes
Report Details
Report Title
Bilastine Market Research Report
By Type
Hospital, Drug Store
By Application
Urticaria, Allergic Rhinitis, Allergic Rhinoconjunctivitis
By Companies
Aralez Pharmaceuticals, Takeda, Menarini, Taiho Yakuhin, Faes Farma, Berlin Chemie, GlaxoSmithKline, Pierre Fabre
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
134
Number of Tables & Figures
94
Customization Available
Yes, the report can be customized as per your need.
Global Bilastine Market Report Segments:
The global Bilastine market is segmented on the basis of:
Types
Hospital, Drug Store
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Urticaria, Allergic Rhinitis, Allergic Rhinoconjunctivitis
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Aralez Pharmaceuticals
- Takeda
- Menarini
- Taiho Yakuhin
- Faes Farma
- Berlin Chemie
- GlaxoSmithKline
- Pierre Fabre
Highlights of The Bilastine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hospital
- Drug Store
- By Application:
- Urticaria
- Allergic Rhinitis
- Allergic Rhinoconjunctivitis
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bilastine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bilastine is a medication used to treat eye allergies. It works by blocking the release of histamine, which is responsible for the symptoms of an allergic reaction.
Some of the major players in the bilastine market are Aralez Pharmaceuticals, Takeda, Menarini, Taiho Yakuhin, Faes Farma, Berlin Chemie, GlaxoSmithKline, Pierre Fabre.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bilastine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bilastine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bilastine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bilastine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bilastine Market Size & Forecast, 2018-2028
4.5.1 Bilastine Market Size and Y-o-Y Growth
4.5.2 Bilastine Market Absolute $ Opportunity
Chapter 5 Global Bilastine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Bilastine Market Size Forecast by Type
5.2.1 Hospital
5.2.2 Drug Store
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Bilastine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Bilastine Market Size Forecast by Applications
6.2.1 Urticaria
6.2.2 Allergic Rhinitis
6.2.3 Allergic Rhinoconjunctivitis
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bilastine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bilastine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Bilastine Analysis and Forecast
9.1 Introduction
9.2 North America Bilastine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Bilastine Market Size Forecast by Type
9.6.1 Hospital
9.6.2 Drug Store
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Bilastine Market Size Forecast by Applications
9.10.1 Urticaria
9.10.2 Allergic Rhinitis
9.10.3 Allergic Rhinoconjunctivitis
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Bilastine Analysis and Forecast
10.1 Introduction
10.2 Europe Bilastine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Bilastine Market Size Forecast by Type
10.6.1 Hospital
10.6.2 Drug Store
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Bilastine Market Size Forecast by Applications
10.10.1 Urticaria
10.10.2 Allergic Rhinitis
10.10.3 Allergic Rhinoconjunctivitis
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Bilastine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Bilastine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Bilastine Market Size Forecast by Type
11.6.1 Hospital
11.6.2 Drug Store
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Bilastine Market Size Forecast by Applications
11.10.1 Urticaria
11.10.2 Allergic Rhinitis
11.10.3 Allergic Rhinoconjunctivitis
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Bilastine Analysis and Forecast
12.1 Introduction
12.2 Latin America Bilastine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Bilastine Market Size Forecast by Type
12.6.1 Hospital
12.6.2 Drug Store
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Bilastine Market Size Forecast by Applications
12.10.1 Urticaria
12.10.2 Allergic Rhinitis
12.10.3 Allergic Rhinoconjunctivitis
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Bilastine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Bilastine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Bilastine Market Size Forecast by Type
13.6.1 Hospital
13.6.2 Drug Store
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Bilastine Market Size Forecast by Applications
13.10.1 Urticaria
13.10.2 Allergic Rhinitis
13.10.3 Allergic Rhinoconjunctivitis
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bilastine Market: Competitive Dashboard
14.2 Global Bilastine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Aralez Pharmaceuticals
14.3.2 Takeda
14.3.3 Menarini
14.3.4 Taiho Yakuhin
14.3.5 Faes Farma
14.3.6 Berlin Chemie
14.3.7 GlaxoSmithKline
14.3.8 Pierre Fabre
